Anti PDCD1 pAb (ATL-HPA035981 w/enhanced validation)

Atlas Antibodies

Catalog No.: ATL-HPA035981-25

Protein Description: programmed cell death 1
Gene Name: PDCD1
Alternative Gene Name: CD279, hSLE1, PD1, SLEB2
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000026285: 63%, ENSRNOG00000049797: 66%
Entrez Gene ID: 5133
Uniprot ID: Q15116
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Product Specifications

• Application: WB, IHC
• Reactivity: Human
• Clonality: Polyclonal
• Host: Rabbit
• Immunogen: WFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAIS
• Gene Sequence: WFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAIS
• Gene ID - Mouse: ENSMUSG00000026285
• Gene ID - Rat: ENSRNOG00000049797
• Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.

Citations for Anti PDCD1 pAb (ATL-HPA035981 w/enhanced validation) – 7 Found

Jiang, Liyan; Su, Xinying; Zhang, Tianwei; Yin, Xiaolu; Zhang, Meizhuo; Fu, Haihua; Han, Hulin; Sun, Yun; Dong, Lili; Qian, Jialin; Xu, Yanhua; Fu, Xuan; Gavine, Paul R; Zhou, Yanbin; Tian, Kun; Huang, Jiaqi; Shen, Dong; Jiang, Haiyi; Yao, Yihong; Han, Baohui; Gu, Yi. PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC). Oncotarget. 2017;8(16):26845-26857. 

McGary, Colleen S; Deleage, Claire; Harper, Justin; Micci, Luca; Ribeiro, Susan P; Paganini, Sara; Kuri-Cervantes, Leticia; Benne, Clarisse; Ryan, Emily S; Balderas, Robert; Jean, Sherrie; Easley, Kirk; Marconi, Vincent; Silvestri, Guido; Estes, Jacob D; Sekaly, Rafick-Pierre; Paiardini, Mirko. CTLA-4(+)PD-1(-) Memory CD4(+) T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques. Immunity. 2017;47(4):776-788.e5. 

Xu-Monette, Zijun Y; Zhou, Jianfeng; Young, Ken H. PD-1 expression and clinical PD-1 blockade in B-cell lymphomas. Blood. 2018;131(1):68-83. 

Johnson, Douglas B; McDonnell, Wyatt J; Gonzalez-Ericsson, Paula I; Al-Rohil, Rami N; Mobley, Bret C; Salem, Joe-Elie; Wang, Daniel Y; Sanchez, Violeta; Wang, Yu; Chastain, Cody A; Barker, Kristi; Liang, Yan; Warren, Sarah; Beechem, Joseph M; Menzies, Alexander M; Tio, Martin; Long, Georgina V; Cohen, Justine V; Guidon, Amanda C; O'Hare, Méabh; Chandra, Sunandana; Chowdhary, Akansha; Lebrun-Vignes, Bénédicte; Goldinger, Simone M; Rushing, Elisabeth J; Buchbinder, Elizabeth I; Mallal, Simon A; Shi, Chanjuan; Xu, Yaomin; Moslehi, Javid J; Sanders, Melinda E; Sosman, Jeffrey A; Balko, Justin M. A case report of clonal EBV-like memory CD4(+) T cell activation in fatal checkpoint inhibitor-induced encephalitis. Nature Medicine. 2019;25(8):1243-1250. 

Al-Badran, Sara Sf; Grant, Lauren; Campo, Maejoy V; Inthagard, Jitwadee; Pennel, Kathryn; Quinn, Jean; Konanahalli, Prakash; Hayman, Liam; Horgan, Paul G; McMillan, Donald C; Roxburgh, Campbell Sd; Roseweir, Antonia; Park, James H; Edwards, Joanne. Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer. The Journal Of Pathology. Clinical Research. 2021;7(2):121-134. 

He, Mengdi; Wang, Yiying; Zhang, Guodong; Cao, Kankan; Yang, Moran; Liu, Haiou. The prognostic significance of tumor-infiltrating lymphocytes in cervical cancer. Journal Of Gynecologic Oncology. 2021;32(3):e32. 

von der Grün, Jens; Winkelmann, Ria; Burck, Iris; Martin, Daniel; Rödel, Franz; Wild, Peter Johannes; Bankov, Katrin; Weigert, Andreas; Kur, Ivan-Maximiliano; Brandts, Christian; Filmann, Natalie; Issing, Christian; Thönissen, Philipp; Tanneberger, Anna Maria; Rödel, Claus; Ghanaati, Shahram; Balermpas, Panagiotis. Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial. Frontiers In Oncology. 12( 35402268):817692.